University of California San Francisco
Give to UCSF
Early-stage breast cancer patients whose tumors carry genetic markers associated with a low risk of disease recurrence may not need to undergo chemotherapy, suggests a new study that employed a test devised by a UCSF researcher.
The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UCSF and University of Wisconsin researchers.
A previously unidentifiable type of low-grade inflammation may explain why common anti-inflammatory drugs such as aspirin have shown promise against some types of cancer – even when patients don’t display typical signs of inflammation.
Three UCSF faculty members participated in the White House Cancer Moonshot Summit, at which the University of California committed to a new transformative model for health care delivery for breast cancer patients.
Esteban G. Burchard has become a leading national voice for increasing diversity in the biomedical research workforce, which he sees as deeply tied to racial inequalities in health care.
Two UCSF scientists have been named Pew scholars in the biomedical sciences.
Children aged 6 and under with intermittent wheezing triggered by colds may not need to take inhaled steroids on a daily basis to limit the flare-ups that can result in emergency treatment.
UCSF has received a four-year, $2.4 million National Institutes of Health grant for an international study on the potential of femoral fractures from osteoporosis drugs.
UCSF surgeons performed the first Osseoanchored Prosthesis for the Rehabilitation of Amputees surgery in the U.S. – a surgery that will allow an external prosthesis to be anchored directly to the patient’s remaining bone.
Time magazine has named internationally renowned breast cancer oncologist Laura Esserman to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.
The new UCSF Center for BRCA Research – which spans basic and translational research, clinical care and education – provides a one-stop resource for patients and individuals who carry BRCA1 and BRCA2 mutations.
